Elavil and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Elavil (amitriptyline hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Ativan, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Elavil. It is created by eHealthMe based on reports of 19,133 people who have side effects when taking Elavil from the FDA, and is updated regularly.

What is Elavil?

Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. eHealthMe is studying from 20,724 Elavil users. Check the latest studies of Elavil.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,493 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

On Jul, 13, 2026

19,133 people reported to have side effects when taking Elavil.
Among them, 95 people (0.5%) have Visual acuity reduced.

Could Elavil cause Visual acuity reduced?

Among these 95 people:

How long have people been on Elavil when they have Visual acuity reduced? *

What is the gender of people who have Visual acuity reduced when taking Elavil? *

female: 78.72 %
male: 21.28 %

What is the age of people who have Visual acuity reduced when taking Elavil? *

What are other drugs people take besides Elavil? *

What are other side effects people have besides Visual acuity reduced? *

Weakness: 29 people, 30.53%
Headache (pain in head): 28 people, 29.47%
Fall: 27 people, 28.42%
Pain: 27 people, 28.42%
Stress And Anxiety: 26 people, 27.37%
Fever: 26 people, 27.37%
Muscle Aches (muscle pain): 25 people, 26.32%
Weight Decreased: 24 people, 25.26%
Injury: 24 people, 25.26%
Fatigue (feeling of tiredness): 24 people, 25.26%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 11.58%
Osteoporosis (bones weak and more likely to break): 10 people, 10.53%
High Blood Pressure: 9 people, 9.47%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 9.47%
Pain: 7 people, 7.37%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 5.26%
Urinary Tract Infection: 5 people, 5.26%
Stress And Anxiety: 5 people, 5.26%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 4.21%
Diabetes: 4 people, 4.21%

* Approximation only. Some reports may have incomplete information.

Do you take Elavil and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elavil:

Elavil (20,724 reports)

Browse all side effects of Elavil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,493 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,887 conditions)

Related publications that referenced our studies

Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride (the active ingredients of Elavil) and Elavil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.